Product
IM-01
1 clinical trial
1 indication
Indication
Clostridium difficile infectionClinical trial
Clinical Effectiveness of Egg-derived Polyclonal Antibodies (IM-01) for the Treatment of Mild-moderate Clostridium Difficile Infection (CDI)Status: Recruiting, Estimated PCD: 2023-12-30